Objective: Infusion of angiotensin II (AngII) during the third and fourth week after balloon injury of the left common carotid artery of the rat induces smooth muscle cell (SMC) DNA synthesis. In this study we wanted to investigate whether o,-adrenoreceptors are involved in AngII-induced SMC DNA synthesis in the neointima. Methods: Adult male Wistar Kyoto rats were subcutaneously infused for 2 weeks with AngII and the cr,-adrenoreceptor antagonist doxazosin during the 3rd and the 4th week after balloon injury of the left common carotid artery. Control groups received AngII, 0.9% NaCl, AngII + 50% dimethylsulfoxide (DMSO, the solvent of doxazosin), doxazosin or 50% dimethylsulfoxide. Each rat received 5-bromo-2'-deoxyuridine in a separate osmotic minipump to label DNA-synthesizing SMC. Systolic blood pressures were measured in all groups. Results: Angiotensin II caused an increase in systolic blood pressure, whereas addition of doxazosin did not affect the increase in SBP caused by AngII. In the media of the non-injured carotid artery, AngII increased SMC DNA synthesis, as the BrdUrd labeling fraction increased from 0.2 + 0.1% (mean + s.e.m.) in the NaCl group towards 3.4 + 0.6% in the AngII group. Coinfusion with doxazosin reduced the AngII-induced increase in BrdUrd labeling fraction from 3.2 + 0.8% in the AngII + DMSO group towards 0.6 + 0.2% in the AngII f doxazosin group. A similar effect of doxazosin was found in the media of the injured left carotid artery, in which coinfusion with doxazosin also reduced the BrdUrd labeling fraction from 2.6 f 0.8% in the AngII + DMSO group towards 0.3 +-0.1% in the AngII + doxazosin group. In the neointima of the injured left carotid artery, AngII increased the BrdUrd labeling fraction from 11.7 f 1.6% in the NaCl group towards 28.0 + 3.4% in the AngII group. Coinfusion with doxazosin did not influence the AngII-induced SMC DNA synthesis, since the BrdUrd labeling fraction in the neointima of the AngII + doxazosin group was 22.5 f 2.9%. whereas the neointimal BrdUrd labeling fraction in the AngII + DMSO group was 22.9 + 2.3%. Little effect was found on the medial cross-sectional area. The neointimal cross-sectional area was increased as a result of infusion of AngII (0.12 f 0.01 mm2 vs. 0.18 f 0.01 mm2), and coinfusion of doxazosin did not reduce the AngII-induced increase in neointimal cross-sectional area (0.18 f 0.03 mm2). Conclusions: These data suggest that a,-adrenoreceptors are not involved in AngII-induced neointimal SMC DNA synthesis and cross-sectional area, but only play a role in the media of the carotid artery.
restimulates replication in an existing rat carotid neointima [21. In vitro, AngII has been shown to stimulate modestly vascular smooth muscle cell DNA synthesis [3] . However, the proliferative capacity of AngII in vitro is variable from report to report and seems to depend on other factors present in the serum 141, or the stimulation of other growth regulatory systems in the SMC, such as PDGF-A and TGF-/3, [5,61, suggesting an interaction between growth factor(s) and AngII in the induction of SMC growth. Possible mediators in vivo include increased blood pressure and an increased activity of the sympathetic nervous system. AngII enhances noradrenergic activity through presynaptic facilitation of norepinephrine release and subsequent potentiation of post-junctional responses of SMC to (Y ,-adrenoreceptor stimulation [7, 8] . Besides the effects of AngII on sympathetic nerve endings, AngII exerts several other effects on the sympathetic nervous system, including a central action to increase sympathetic outflow, stimulator-y effects on sympathetic ganglia and the adrenal medulla [9] . Evidence that the sympathetic nervous system regulates growth of the arterial wall comes from several sources. Bevan showed that sympathectomy decreases DNA synthesis of the rabbit central ear artery [lo] . These effects in medium sized arteries are consistent with microvascular studies associating sympathetic output with the ability of hypertension to thicken the vessel wall [ 111. Here we studied effects in rat carotid arteries with an already existing neointima and hypothesized that the growth stimulatory effects of AngII on neointimal SMC DNA synthesis and the increase in cross-sectional area are also mediated via cr,-adrenoreceptors. To evaluate this hypothesis, AngII was infused together with the (Y ,-adrenoreceptor antagonist doxazosin in the 3rd and 4th week after balloon injury of the left common carotid artery. At the same time S-bromo-2'-deoxyuridine (BrdUrd) was infused to label DNAsynthesizing smooth muscle cells. The results indicate the involvement of the a,-adrenoreceptor in the AngII-induced SMC DNA synthesis in the media, but not in the neointima of the rat carotid artery.
Materials and methods
Male adult Wistar Kyoto rats (body weight 280-300 g) were obtained from local inbred strains (University of Limburg). Food and tap water were provided ad libitum.
At day 0 the left common carotid artery of all rats was balloon injured. Two weeks after balloon injury, infusions were started and they lasted for 2 weeks. Rats were randomly divided into 6 groups and received either AngII (n = 7), 0.9% NaCl (n = 5), AngII and doxazosin (in 50% dimethylsulfoxide, DMSO) (n = 7), AngII and 50% DMSO (n = 7), doxazosin (n = 5) or 50% DMSO (n = 6). The experiments were performed in accordance with local institutional guidelines.
Blood pressure measurement
Systolic blood pressures @BP) were measured by tailcuff plethysmography (BIT, Life Science, Woodland Hills, CA, USA) on conscious slightly restrained rats. Before the start of the experiments the rats were familiarized three times with the manipulations and restraint. Measurements were started 1 week before balloon injury and performed l-2 times per week; each time the mean of three measurements per animal was used.
Balloon injury of the left common carotid artery
The rats were anesthetized with pentobarbital (60 mg/ml, Veterinary Laboratories Inc.). A H,O-filled embolectomy catheter (2F Fogarty, Baxter, Maarsen, The Netherlands) was inserted into the left external carotid artery, and passed down through the common carotid artery, into the descending thoracic aorta. The balloon was inflated to obtain slight resistance and withdrawn while rotating. After three repeated denudations the catheter was removed, the external carotid ligated, and the wound closed. Blood flow was maintained through the common and internal carotid arteries [2] . The non-injured right carotid artery served as an internal control.
Drug infusion protocol
Drug infusion was started 2 weeks after balloon injury. Drugs were administered by osmotic minipumps (Alza Corp., Palo Alto, CA, USA) that were implanted subcutaneously (s.c.) between the shoulder blades under ether anesthesia. [Val']-Angiotensin II (Sigma Chemical Co., St. Louis, MO, USA) was dissolved in 0.9% NaCl and infused at a rate of 0.5 mg/kg day-' (Alzet model 2002). Doxazosin (a gift from Pfizer, UK) was infused at a rate of 2 mg/kg day-' (Alzet model 2mll) and, because of low solvability and according to the manufacturers' instructions, was dissolved in 50% DMSO. At the same time, all rats received BrdUrd (Serva, Heidelberg, FRG) in 0.9% NaCl at an infusion rate of 0.8 mg/kg day-' via a separate subcutaneous osmotic minipump (Alzet model 2002). All infusions were continued for 2 weeks. The minipumps filled with doxazosin or solvent (Alzet model 2mll) were replaced after 1 week.
Tissue processing
At the end of week 4, the rats were killed with pentobarbital, and the vascular bed was perfusion-fixed with 10% phosphate-buffered formalin via a cannula inserted into the abdominal aorta, at 100 mmHg perfusion pressure. Both the left and right carotid arteries were isolated and fixed overnight in 10% phosphate-buffered formalin. A 2 mm ring of the carotid artery was cut 1 cm cranial from the aortic arch and routinely processed for paraffin embedding.
Immunohistochemistry
Cross-sections (4 pm> were cut and stained immunohistochemically for BrdUrd. BrudUrd labeled nuclei were visualized using an indirect enzyme-labeled antibody technique [20] . Briefly, after rehydration of the sections, blocking of endogenous peroxidase, washing in phosphatebuffered saline pH 7.4, and digestion in 0.05 mg/ml pepsin (Boehringer, Mannheim, FRG) in 0.1 N HCl (30 min, 37"C), the sections were incubated in 2 N HCl (15 min, 37°C) and washed in 0.1 M sodium tetraborate pH 8.5. Sections were incubated with a monoclonal mouse anti-BrdUrd antibody (Eurodiagnostics, Apeldoom, The Netherlands) for 1 h at 37°C followed by incubation with biotinylated rabbit anti-mouse IgG (Amersham, UK) at room temperature for 30 min. Sections were labeled for 30 min with an avidin/biotin-peroxidase complex (Vectastain-ABC kit, Vector Labs, Burlingame, CA). 3,3'Diaminobenzidine was used as the chromogen and the sections were counterstained with hematoxylin. After immunostaining, the cumulative labeling fraction (= [BrdUrd positive cells/total number of cells] x lOO%.) was determined by counting the number of labeled cells and the total number of cells in the media or the neointima.
Morphometry
The cross-sectional areas (CSA) of the media and neointima were measured on 4 pm cross-sections stained with Lawson's solution (Boom B.V., Meppel, The Netherlands) using a computerized morphometry system (Quantimet 570, Leica, Cambridge, UK). The CSA of the media was defined as the area enclosed within the external and internal elastic lamina. The CSA of the neointima was represented by the area enclosed within the internal elastic lamina and the lumen. Two sections per carotid artery were evaluated.
Assessment of cr,-adrenoreceptor blockade with doxazosin
The dose of doxazosin was tested in a separate experiment. Wistar Kyoto rats (n = 10) were continuously infused by S.C. implanted minipumps (Alzet model 2mll) filled with either doxazosin (1 mg/kg h-' ) or 50% DMSO for 1 week, After 1 week, the rats were anesthetized with sodium pentobarbital(60 mg/kg i.p.) and a PE-10 catheter was implanted in the abdominal aorta via a femoral artery to measure mean arterial pressure. A second PE-10 catheter was introduced in the abdominal vena cava via a femoral vein for phenylephrine infusions. The arterial catheter was connected to a displacement pressure transducer (Honeywell microswitch, DCpex, De Bilt, The Netherlands) to measure mean arterial pressures and heart rates in conscious rats. Dose-response curves were obtained by relating pressor responses to the logarithm of the infusion rate of phenylephrine (0.01 to 100 pg/kg per minute). The ED,, was determined as the dose resulting in 50% of the maximal response.
Statistics
Comparisons between groups for BrdUrd labeling fraction or CSA were made by one-way analysis of variance (ANOVA). Comparisons between groups for blood pressure were made by two-way ANOVA. If ANOVA indicated significant differences between the groups, a Bonferroni t-test was performed. Comparisons were made per artery segment, e.g. the neointima, the media of the injured left carotid artery, and the media of the non-injured right carotid artery. Comparisons were also made between the left and right carotid media. Data are expressed as mean + s.e.m.; differences are regarded as statistically significant if P < 0.05.
Results

Assesment of a,-adrenoreceptor blockade with doxclzosin
At a doxazosin dose of 1 mg/kg h-' , the ED,, for phenylephrine was 0.10 f 0.02 pg/kg min-' in control (50% DMSO) rats (n = 5) and 5.5 + 1.3 pg/kg min-' in doxazosin-treated rats (n = 5). In the present study doxazosin was used in a dose of 2 mg/kg h-' indicating an approximate lOO-fold shift in the dose-response curve of phenylephrine.
Effects of AngIl and doxazosin on systolic blood pressure
One week before balloon injury, systolic blood pressures were appromimately 130 mmHg and there was no difference in SBP between the groups. Balloon injury did not affect systolic blood pressure (Fig. 1) . Infusion of AngII increased the SBP by approximately 60 mmHg within the first week of infusion, and the SBP remained increased during the second week of infusion. Addition of 50% DMSO did not affect the increase in SBP caused by Two weeks after balloon injury 2-week infusions were started. Group NaCl (n = 5) received 0.9% NaCI, group AngII (n = 7) received AngII, group AngII + DMSO (n = 7) received AngII and 50% DMSO, group AngII + doxa (n = 7) received AngII and doxazosin (dissolved in 50% DMSOI, group DMSO (n = 6) received 50% DMSO, and group doxa (n = 5) received doxazosin. * Significantly different from NaCI for the entire duration of the experiment, mean If: s.e.m., P < 0.05.
AngII. Infusion of AngII and doxazosin also increased SBP to levels comparable to those in the AngII and AngII + DMSO group. The SBP in all the AngII-treated groups (AngII, AngII + DMSO, and AngII + doxa) increased in comparison with the 0.9% NaCl and 50% DMSO-treated groups, which remained unchanged during the course of the experiment.
3.3. SMC DNA synthesis 3.3.1. Effects of AngII and doxazosin on medial SMC DNA synthesis
In the media of the non-injured right carotid artery of the rats infused with 0.9% NaCl the BrdUrd labeling fraction was 0.2 f 0.1%. Infusion of AngII significantly increased SMC DNA synthesis (Table 1 ). The labeling fraction of the rats that received both AngII and DMSO was similar to the labeling fraction in the AngII-infused rats and coinfusion of doxazosin significantly reduced the labeling fraction. The BrdUrd labeling fractions of the rats treated with DMSO and doxazosin alone were not different from the labeling fraction of the NaCl group.
In the media of the injured left carotid artery, AngII infusion showed a tendency to increase the labeling fraction (Table 1 , AngII vs. NaCl, P = 0.11). Infusion of AngII and DMSO resulted in a BrdUrd labeling fraction of 2.6 & 0.8%. Infusion of doxazosin reduced the BrdUrd labeling fraction in comparison with the AngII + DMSO group. The BrdUrd labeling fractions in the DMSO and doxazosin group were not different from the labeling fraction in the NaCl group. In the neointima, the BrdUrd labeling fraction of the NaCl group was 11.7 + 1.6% (Table 1) . AngII infusion significantly increased the neointimal BrdUrd labeling fraction. The labeling fraction in the neointima of the AngII + DMSO group was not different from the neointima1 BrdUrd labeling fraction in the AngII group (P = 0.16). Infusion of doxazosin resulted in a labeling fraction which was not different from the labeling fraction in the AngII + DMSO group. Infusion of DMSO alone, and infusion of doxazosin alone resulted in labeling fractions in the neointima which were not different from the neointimal labeling fraction in the NaCl-treated rats. In the non-injured right carotid media, infusion of AngII significantly increased the medial CSA (Table 2) . In all other groups (AngII + DMSO, AngII + doxazosin, DMSO alone, and doxazosin alone) the medial CSA was comparable to the NaCl group. Infusion of AngII + DMSO, DMSO, Table 2 Effects of AngII and doxazosin on cross-sectional areas (mm*) in me balloon-injured left carotid artery and the non-injured right carotid artery 28 davs after balloon iniurv. Data are exnressed as mean f s.e.m. or doxazosin resulted in medial cross-sectional areas that were significantly different from the medial CSA of the AngII-treated rats.
In the injured left carotid media, AngII did not significantly increase the medial cross-sectional area. The medial CSA of all groups was comparable to the medial CSA of the NaCl-treated group.
In the neointima, AngII infusion significantly increased the cross-sectional area. Addition of DMSO to AngII did not affect neointimal CSA. Infusion of doxazosin did not influence the AngII-induced neointimal thickening. Infusion of DMSO alone, or doxasosin alone resulted in neointimal CSAs, which were comparable to the neointimal CSA of the NaCl group.
Discussion
The observations made in this study first of all confirm the results of earlier studies that neointimal SMC are more sensitive to the stimulatory effects of AngII on DNA synthesis than medial SMC [2, 21] . The reduction of the AngII-induced increase in medial SMC DNA synthesis by co-treatment with the cy , -adrenoreceptor blocker doxazosin confirms our previous result that co-treatment with AngII and another selective (Y I -adrenoreceptor blocker prazosin reduces the AngII-induced increase in medial SMC DNA synthesis of the carotid artery [14] . The similar effect of both prazosin and doxazosin on medial SMC DNA synthesis indicates that the action of these cr,-adrenoreceptor antagonists is class specific and due to the blockade of the (Y , -adrenoreceptor.
Despite the efficacy of the (Y, -adrenoreceptor antagonist to reduce the AngII-induced increase in SMC DNA synthesis in the media, doxazosin failed to inhibit AngII-induced replication in the neointima of the injured carotid artery. The failure of the antagonist to lower these replication rates cannot be explained on the basis of a dose problem; doxazosin caused an approximate lOO-fold shift in the dose-response curve of phenylephrine, which indicates effective cr,-adrenoreceptor blockade. Moreover, the drug was effective in lowering medial SMC DNA synthesis in the same rats. Possible a,-adrenoreceptor blocking effects of doxazosin are unlikely. Although doxazosin, like other cu,-adrenoreceptor antagonists, has the ability to block cu,-adrenoreceptors, data from ligand binding studies and experiments in rabbit pulmonary arteries show that doxazosin is even more selective for (Y,-versus q adrenoreceptors than prazosin, and has a 600 times higher affinity for al-than qadrenoreceptors [22] . Also, the lack of effect of doxazosin on neointimal SMC DNA synthesis can not be explained by an absence of exposure of the neointima to catecholamines, since infusion of AngII (at a dose of 0.5 mg/kg day-' > induces a three-fold increase in plasma norepinephrine and epinephrine concentrations in comparison with NaCl-infused rats (E. van Kleef, unpublished observations).
The lack of effect of doxazosin in the neointima in the present study provides an intriguing contrast with other studies using cu,-adrenoreceptor antagonists in the balloon injury model in the rat and the rabbit. Prazosin, when administered directly after injury, reduces SMC DNA synthesis in the media [23] and neointima formation in the rat carotid artery [ 171, and both prazosin and doxazosin reduce neointimal formation in the rabbit abdominal aorta [ 15,161. The difference in effects of a 1 -adrenoreceptor blockade on the neointima between the data in the literature and the results of the present study, may indicate that cr,-adrenoreceptors play a role in replication in the media during normal development and in the initial response of a vessel wall to injury, but not in neointimal replication, at least not during the 3rd and 4th week after injury.
The data from this experiment show that at 4 weeks after injury selective adrenergic blockade does not affect neointimal SMC DNA synthesis and neointimal cross-sectional area. The absence of an adrenergic response has previously been demonstrated for adrenergic function. Until 6 weeks after balloon injury of the rabbit iliac artery, the adrenergic function is reduced as demonstrated by a lower sensitivity and lower maximal response of the injured artery to exogenous norepinephrine [24] . Several possible explanations can be given for the absence of an adrenergic response after balloon injury. Firstly, it is possible that the number of adrenoreceptors is very low in the neointima, or that adrenoreceptors are present in the neointima but functionally inactive. Evidence for the first possibility comes from preliminary data from radioligand binding studies with [3H]-labeled prazosin which show that 2 weeks after balloon injury of the rat carotid artery the amount of cr,-adrenoreceptors is significantly reduced in comparison with the non-injured right carotid artery (J.G.R. De Mey, unpublished observations). Secondly, it is possible that the different adrenoreceptor subtypes, (Y ,*, n, c and (~,n are present in the neointimal vascular smooth muscle, but differ in the extent in which the subtypes participate in growth regulation. Adrenoreceptor mRNA synthesis of QIB,C md aID has been localized in the media of the rat aorta, renal artery, and mesenteric resistance artery by in situ hybridization [25] . No data are yet available on mRNA expression of a,-adrenoreceptors in the rat carotid neointima.
The observation that the cY,-adrenoreceptor is not involved in the induction of SMC DNA synthesis by AngII in the existing neointima, suggests that AngII mediates SMC DNA synthesis in the neointima via other pathways. The increased blood pressure during AngII infusion does not seem to be an important contributor to the increase in SMC DNA synthesis, since both doxazosin and prazosin [14] were able to reduce the AngII-induced increase in DNA synthesis in the media of the carotid artery, without lowering the blood pressure increase. Also, other studies have shown that AngII can induce medial hypertrophy of the rat superior mesenteric artery [26] and rat vascular smooth muscle DNA synthesis [27] independent of blood pressure. Another possibility is that AngII directly influences neointimal SMC DNA synthesis via AngII receptors (AT-receptors). In all in vivo studies but one [28] , selective blockade of the AT,-receptor inhibits neointima formation when treatment is started immediately after balloon injury . Also, recent observations from our own laboratory indicate that blockade of the AT, receptor during the 3rd and 4th week 'after injury reduces the AngII-induced neointimal thickening, whereas blockade of the AT, receptor by PD123319 has no effect [32] , Autoradiography has shown the presence of AT receptors in the rat thoracic aorta, of which 80% are of the AT,-receptor type and 20% of the AT,-receptor type [33] . The rat aortic neointima at 15 days after balloon injury contains predominantly AT,-receptors [33] .
The effects of AngII and doxazosin on medial and neointimal cross-sectional area were less pronounced. AngII induced an increase in cross-sectional area in the media of the non-injured right carotid artery, and in the neointima of the injured left carotid artery, which has previously been demonstrated in the balloon-injured carotid artery and other arteries [2, 21, 26, 34] . Doxazosin did not affect the cross-sectional area in the media of the non-injured right carotid artery, nor of the media and neointima of the injured left carotid artery.
Also, DMSO had no effects on SMC DNA synthesis or cross-sectional area. Effects of DMSO on cross-sectional area have not been described in literature. There are some studies on the effects of DMSO on vascular SMC DNA synthesis. Its effects vary between no effect at all and a reduction of SMC DNA synthesis [35, 36] .
The diverse effects of AngII and cr,-adrenoreceptor blockade on medial and neointimal SMC are examples of diversity in growth responses of medial and neointimal SMC. In vivo, differences between medial and neointimal SMC have been found in gene and protein expression patterns of components of the renin angiotensin system [37] , cytoskeletal markers [18, 38] and their sensitivity to growth stimuli such as AngII [2] . In vitro, also differences in proliferation capacity and morphologic features have been found [39, 40] . The studies presented here are another example of differences between medial and neointimal SMC growth regulation. They show that (Y,-adrenoreceptors are involved in AngII-induced medial SMC DNA synthesis, but not neointimal SMC DNA synthesis, at least not during the 3th and 4th week after balloon injury. The different growth response of medial versus neointimal SMC may have important clinical consequences. Treatment with (Y,-adrenoreceptor antagonists, or other drugs like ACE inhibitors and the AT, receptor antagonist losartan has been shown to be effective in reducing neointima formation in animal models, whereas for example the ACE inhibitor cilazapril did not prevent restenosis in clinical trials [41] . The different results between the animal and human studies might be the result of the heterogeneity in the growth response of medial and neointimal SMC. Whereas most intervention studies in animals deal with the proliferative characteristics of the normal vessel wall, involving medial SMC replication and migration, the studies presented here suggest that quite different results can be obtained if the vessel wall has an already formed neointima.
